Canada Cardiovascular Devices Market By Product (Diagnostic and Monitoring(ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, Pet Scan, MRI, Cardiac CT, Doppler Fetal Monitors), By Surgical Devices (Pacemakers, Stents, Catheters and accessories, Guidewires, Cannulae, Electrosurgical, Procedures, Valves, Occlusion Devices)), By Application(Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, Others), By End-User(Hospitals, Ambulatory Surgical Centres, Cardiac Centers) and Geography

Canada Cardiovascular Devices Market size was valued at US$ billion in 2023. and is poised to grow at a CAGR of 4.0% from 2024 to 2030. The market report provides a detailed overview of the Canada Cardiovascular Devices Market, segmented by product, surgical devices, application, and end-user. By product, the Canadian cardiovascular devices market has been segmented into Diagnostic and Monitoring (ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, PET scan, MRI, Cardiac CT, Doppler Fetal Monitors. The ECG segment is likely to be the largest and fastest-growing in terms of various products. For surgical devices, the Canadian cardiovascular devices market has been segmented into Pacemakers, Stents, Catheters and accessories, Guidewires, Cannulae, Electrosurgical, Procedures, Valves, and Occlusion Devices.

The Pacemakers segment is expected to account for a significant revenue share in 2022-2028. By application, the Canadian cardiovascular devices market has been segmented into Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others. The Coronary Heart Disease segment accounted for a high revenue share in 2021. Based on end-user, the Canadian cardiovascular devices are segmented into Hospitals, Ambulatory Surgical Centres, and Cardiac Centers. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.

Key Development:

• In December 2020, Abbott launched a clip delivery system to treat a patient suffering from mitral regurgitation.